FDG-PET findings in patients with galactosaemia

Journal of Inherited Metabolic Disease

Volumn 31, Issue 4, 2008, Pages 533-539

  Dubroff, J G ^a   Ficicioglu, C ^b   Segal, S ^b   Wintering, N A ^a   Alavi, A ^a   Newberg, Andrew B ^a  

^a HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FLUORODEOXYGLUCOSE F 18; GALACTOSE; GLUCOSE;

ADULT; ARTICLE; BRAIN DYSFUNCTION; BRAIN FUNCTION; BRAIN METABOLISM; BRAIN REGION; CAUDATE NUCLEUS; CEREBELLUM; CINGULATE GYRUS; CLAUSTRUM; CLINICAL ARTICLE; COGNITIVE DEFECT; COMPUTER PROGRAM; CONTROLLED STUDY; DATA ANALYSIS; DIET RESTRICTION; FEMALE; FRONTAL CORTEX; GALACTOSEMIA; GLUCOSE BRAIN LEVEL; GLUCOSE METABOLISM; HUMAN; MALE; METHODOLOGY; NEUROLOGIC DISEASE; OCCIPITAL LOBE; PARAMETRIC TEST; PARIETAL LOBE; POSITRON EMISSION TOMOGRAPHY; SPEECH DISORDER; TREMOR;

ADULT; BRAIN; BRAIN MAPPING; CASE-CONTROL STUDIES; FEMALE; FLUORODEOXYGLUCOSE F18; GALACTOSEMIAS; HUMANS; MALE; MIDDLE AGED; POSITRON-EMISSION TOMOGRAPHY;

EID: 50149116535     PISSN: 01418955     EISSN: 15732665     Source Type: Journal    
DOI: 10.1007/s10545-008-0806-0     Document Type: Article

References (25)

1. al-Essa MA, Rashed MS, Bakheet SM, Patay ZJ, Ozand PT (2000) Glutaric aciduria type II: Observations in seven patients with neonatal- and late-onset disease. J Perinatol 20 (2): 120-128.
2. Fridovich-Keil JL (2006) Galactosemia: The good, the bad, and the unknown. J Cell Physiol 209 (3): 701-705.
3. Friston KJ, Ashburner, J, Frith CD, Poline JB, Heather JD, Frackowiak RSJ (1995) Spatial registration and normalization of images. Hum Brain Mapp 3 (3): 165-189.
4. Fukuda M, Mentis MJ, Ma Y, et al (2001) Networks mediating the clinical effects of pallidal brain stimulation for Parkinson's disease: A PET study of resting-state glucose metabolism. Brain 124 (Pt 8): 1601-1609.
5. Hermann W, Barthel H, Hesse S, et al (2002) Comparison of clinical types of Wilson's disease and glucose metabolism in extrapyramidal motor brain regions. J Neurol 249 (7): 896-901.
6. Hilker R, Voges J, Weisenbach S, et al (2004) Subthalamic nucleus stimulation restores glucose metabolism in associative and limbic cortices and in cerebellum: Evidence from a FDG-PET study in advanced Parkinson's disease. J Cereb Blood Flow Metab 24 (1): 7-16.
7. Huang C, Tang C, Feigin A, et al (2007) Changes in network activity with the progression of Parkinson's disease. Brain 130 (Pt 7): 1834-1846.
8. Karp JS, Surti S, Daube-Witherspoon ME, et al (2003) Performance of a brain PET camera based on anger-logic gadolinium oxyorthosilicate detectors. J Nucl Med 44 (8): 1340-1349.
9. Kaufman FR, Horton EJ, Gott P, et al (1995a) Abnormal somatosensory evoked potentials in patients with classic galactosemia: Correlation with neurological outcome. J Child Neurol 10 (1): 32-36.
10. Kaufman FR, McBride-Chang C, Manis FR, Wolff JA, Nelson MD (1995b) Cognitive functioning, neurological status and brain imaging in classical galactosemia. Eur J Pediatr 154 (7 Supplement 2): S2-5.
11. Lancaster JL, Woldorff MG, Parsons LM, et al (2000) Automated Talairach atlas labels for functional brain mapping. Hum Brain Mapp 10 (3): 120-131.
12. Molnár MJ, Valikovics A, Molnár S, et al (2000) Cerebral blood flow and glucose metabolism in mitochondrial disorders. Neurology 55 (4): 544-548.
13. Moore DF, Herscovitch P, Schiffmann R (2001) Selective arterial distribution of cerebral hyperperfusion in Fabry disease. J Neuroimaging 11 (3): 303-307.
14. Nelson CD, Waggoner DD, Donnell GN, Tuerck JM, Buist NR (1991) Verbal dyspraxia in treated galactosemia. Pediatrics 88 (2): 346-350.
15. Nelson MD Jr, Wolff JA, Cross CA, Donnell GN, Kaufman FR. (1992) Galactosemia: Evaluation with MR imaging. Radiology 184 (1): 255-261.
16. Newberg AB, Alavi A (2005) The role of PET imaging in the management of patients with central nervous system disorders. Radiol Clin North Am 43 (1): 49-65.
17. Newberg A, Cotter A, Udeshi M, Alavi A, Clark C (2003) A metabolic imaging severity rating scale for the assessment of cognitive impairment. Clin Nucl Med 28 (7): 565-570.
18. Resnick SM, Karp JS, Turetsky B, Gur RE (1993) Comparison of anatomically-defined versus physiologically-based regional localization: effects on PET-FDG quantitation. J Nucl Med 34 (12): 2201-2207.
19. Ridel KR, Leslie ND, Gilbert DL (2005) An updated review of the long-term neurological effects of galactosemia. Pediatr Neurol 33 (3): 153-161.
20. Segal S (1998) Komrower Lecture. Galactosaemia today: The enigma and the challenge. J Inherit Metab Dis 21 (5): 455-471.
21. 18 F]FDG PET: A clinical validation of statistical parametric mapping. Neuroimage 9 (1): 63-80.
22. Talairach J, Tournoux P (1988) Co-planar Stereotaxic Atlas of the Human Brain. New York: Thieme.
23. Waggoner DD, Buist NR, Donnell GN (1990) Long-term prognosis in galactosaemia: Results of a survey of 350 cases. J Inherit Metab Dis 13 (6): 802-818.
24. Wang ZJ, Berry GT, Dreha SF, Zhao H, Segal S, Zimmerman RA (2001) Proton magnetic resonance spectroscopy of brain metabolites in galactosemia. Ann Neurol 50 (2): 266-269.
25. Webb AL, Singh RH, Kennedy MJ, Elsas LJ (2003) Verbal dyspraxia and galactosemia. Pediatr Res 53 (3): 396-402.